Company Encyclopedia
View More
name
Virtus Investment
VRTS.US
Virtus Investment Partners, Inc. is a publicly owned investment manager. The firm primarily provides its services to individual and institutional clients. It launches separate client focused equity and fixed income portfolios.
1.124 T
VRTS.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Asset Management and Custody BanksIndustry
Industry Ranking51/119
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE15.07%A
    • Profit Margin15.51%A
    • Gross Margin44.15%B
  • Growth ScoreC
    • Revenue YoY-1.09%D
    • Net Profit YoY14.21%C
    • Total Assets YoY8.46%B
    • Net Assets YoY3.24%C
  • Cash ScoreC
    • Cash Flow Margin644.70%C
    • OCF YoY-1.09%D
  • Operating ScoreD
    • Turnover0.23D
  • Debt ScoreD
    • Gearing Ratio73.81%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Virtus Total Return Fund Inc. Announces Preliminary Results of Tender Offer

    Virtus Total Return Fund Inc. announced preliminary results of its tender offer to acquire up to 10% of its outstanding shares, which expired on December 3, 2025. Approximately 15,013,106 shares were tendered, leading to an oversubscription. The purchase price is set at 98% of the Fund’s net asset value per share, equating to $6.9874. Final results are expected by December 8, 2025. The Fund aims for capital appreciation and income, with investment managed by Virtus Investment Advisers, LLC and subadvisers Duff & Phelps and Newfleet Asset Management.

    fidelity·
    US
    VRTS
    -2.51%
    fidelity·
    US
    VRTS
    -2.51%

    Virtus Advisers LLC Buys New Position in Jacobs Solutions Inc. $J

    Virtus Advisers LLC acquired 2,000 shares of Jacobs Solutions Inc., valued at $263,000. Other institutional investors also increased their stakes. Insiders bought 2,513 shares recently. Analysts have mixed ratings, with a consensus of "Moderate Buy" and an average price target of $155.90. Jacobs Solutions stock opened at $134.99, with a market cap of $16.03 billion.

    Market Beat·
    US
    VRTS
    -2.51%
    US
    J
    +1.44%
    Market Beat·
    US
    VRTS
    -2.51%
    US
    J
    +1.44%

    Virtus Investment Advisers LLC Sells 7,192 Shares of Mineralys Therapeutics, Inc. $MLYS

    Virtus Investment Advisers LLC reduced its stake in Mineralys Therapeutics by 53.3% in Q2, selling 7,192 shares. Other institutional investors adjusted their holdings, with RA Capital, SR One, and Vanguard increasing their stakes. Analysts have mixed ratings, with a consensus of 'Moderate Buy' and an average target price of $46.67. Mineralys' stock opened at $43.16, with a market cap of $3.42 billion. Recent insider transactions include significant stock sales by Director Brian Taylor Slingsby and CFO Adam Scott Levy.

    Market Beat·
    US
    MLYS
    -0.74%
    US
    VRTS
    -2.51%
    Market Beat·
    US
    MLYS
    -0.74%
    US
    VRTS
    -2.51%

    Virtus Investment Advisers LLC Invests $85,000 in Maze Therapeutics, Inc. $MAZE

    Virtus Investment Advisers LLC invested $85,000 in Maze Therapeutics, acquiring 6,940 shares. Other institutional investors have also recently taken positions in the company. Analysts have given Maze Therapeutics a consensus "Buy" rating, with a target price of $38.57. The company's stock opened at $37.75, with a market cap of $1.82 billion. Maze Therapeutics focuses on developing precision medicines for renal, cardiovascular, and metabolic diseases.

    Market Beat·
    US
    MAZE
    +2.68%
    US
    VRTS
    -2.51%
    Market Beat·
    US
    MAZE
    +2.68%
    US
    VRTS
    -2.51%

    Virtus Investment Advisers LLC Sells 38,979 Shares of Tango Therapeutics, Inc. $TNGX

    Virtus Investment Advisers LLC reduced its holdings in Tango Therapeutics, Inc. by 67.7% in Q2, selling 38,979 shares. The firm's remaining 18,620 shares were valued at $95,000. Other institutional investors adjusted their positions, with some increasing their holdings. Tango Therapeutics' stock opened at $10.92, with a market cap of $1.47 billion. Analysts have mixed ratings, with a moderate buy consensus and a price target of $12.50. Recent insider trading saw major shareholder Rock Ventures Iv L.P. Third sell 477,401 shares.

    Market Beat·
    US
    TNGX
    +3.45%
    US
    VRTS
    -2.51%
    Market Beat·
    US
    TNGX
    +3.45%
    US
    VRTS
    -2.51%
    © 2025 Longbridge｜Disclaimer